Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Upper Lobe Predominant Emphysema”

7 trials

Showing 7 of 7 results

Large-scale testing (Phase 3)WithdrawnNCT00716053
What this trial is testing

Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema

Who this might be right for
Advanced Upper Lobe Predominant Emphysema
Aeris Therapeutics 225
Early research (Phase 1)Study completedNCT00884962
What this trial is testing

A Dose Ranging Study of the Aeris Polymeric Lung Volume Reduction (PLVR) System in Patients With Advanced Upper Lobe Predominant Emphysema

Who this might be right for
Advanced Emphysema
Aeris Therapeutics 25
Testing effectiveness (Phase 2)Study completedNCT00515164
What this trial is testing

US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

Who this might be right for
Pulmonary EmphysemaChronic Obstructive Pulmonary Disease
Aeris Therapeutics 22
Post-approval studies (Phase 4)UnknownNCT01460108
What this trial is testing

AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation

Who this might be right for
Pulmonary EmphysemaCOPDLung Diseases
LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology 10
Early research (Phase 1)Study completedNCT00347659
What this trial is testing

US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study

Who this might be right for
Pulmonary Emphysema
Aeris Therapeutics 6
Large-scale testing (Phase 3)WithdrawnNCT01908933
What this trial is testing

Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema

Who this might be right for
EmphysemaChronic Obstructive Pulmonary Disease (COPD)
Aeris Therapeutics
Testing effectiveness (Phase 2)Study completedNCT00435253
What this trial is testing

US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

Who this might be right for
Pulmonary Emphysema
Aeris Therapeutics 20

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation